(19)
(11) EP 4 816 826 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817308.0

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
G01N 33/86(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/86; G01N 2333/75
(86) International application number:
PCT/EP2024/084115
(87) International publication number:
WO 2025/114544 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 EP 23213719

(71) Applicants:
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)

    AL AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR 
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)

    DE 

(72) Inventors:
  • HORN, Carina
    68305 Mannheim (DE)
  • MEYER DOS SANTOS, Sascha
    68305 Mannheim (DE)
  • SCHUMACHER, Dagmar
    68305 Mannheim (DE)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)

   


(54) MEANS AND METHODS FOR DETERMINING FIBRINOGEN USING AN ASSAY BASED ON A COMPETITIVE MECHANISM